N/A
Blood prime for cardiopulmonary bypass for Congenital Heart Disease
N/A
Recruiting
Research Sponsored by Augusta University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Must not have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up30 days
Awards & highlights
No Placebo-Only Group
Study Summary
This trial evaluates if bloodless cardiac surgery has benefits for patients 3.5-12kg, such as reduced morbidity/mortality & shorter hospital stays.
Eligible Conditions
- Congenital Heart Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Age of patients undergoing bloodless cardiac surgery in patients 3.5-12kg (categorical variable)
Blood received during bloodless cardiac surgery in patients 3.5-12kg (categorical variable)
Demographics of bloodless cardiac surgery in patients 3.5-12kg (categorical variable)
+18 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Blood prime for cardiopulmonary bypassActive Control1 Intervention
Group II: clear prime for cardiopulmonary bypassActive Control1 Intervention
Find a site
Who is running the clinical trial?
Augusta UniversityLead Sponsor
205 Previous Clinical Trials
74,890 Total Patients Enrolled
Media Library
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the size of this investigation’s participant pool?
"Indeed, clinicaltrials.gov attests to the active recruitment of 150 patients from one trial site since its posting on May 10th 2023 and subsequent editing on May 19th."
Answered by AI
Is this clinical trial enrolling participants presently?
"Affirmative. Records on clinicaltrials.gov attest to this medical trial's current recruitment efforts, which began on May 10th 2023 and were last amended on May 19th of the same year. The study is searching for 150 patients from a single centre."
Answered by AI